Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1C | Q13936 | 10/20 | 0.53 |
| ▸ | CACNA1F | O60840 | 8/20 | 0.53 |
| ▸ | CACNA1D | Q01668 | 8/20 | 0.53 |
| ▸ | CACNA1S | Q13698 | 8/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7554839 | 0.97 | CACNA1C (0.53) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL7446056 | 0.95 | CYP2C9 (0.54) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL7544621 | 0.94 | CACNA1C (0.54) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL7443841 | 0.93 | CYP2C9 (0.54) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL7540434 | 0.91 | CACNA1C (0.52) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL7396706 | 0.91 | CYP1A2 (0.58) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL7365819 | 0.91 | CYP1A2 (0.58) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL7393785 | 0.91 | CYP1A2 (0.58) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL7445246 | 0.87 | ADORA3 (0.60) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL9248478 | 0.84 | ADORA3 (0.61) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995013812-A1 | USE OF SUBSTITUTED 1,4-DIHYDROPYRIDINE TO REDUCE INTRAOCULAR PRESSURE | BYK NEDERLAND BV (NL) | 1995-05-26 | — | — | WO | claimed |
| US-5378718-A | Cardiovascular activity, hypotensive | CEDONA PHARMACEUTICALS B.V. (NL) | 1995-01-03 | — | — | US | disclosed |